The Delta variant now accounts for more than half of the new coronavirus cases in the United States —52%. Almost all of the new cases — 99.7% —are among people who have not been vaccinated.
Kinda feel bad for the director who just read the guidelines. The one who posted on social media must find out first if the memo was really created by their director before posting…
Since the majority of adults in Israel are fully vaccinated, infections are now very skewed toward teenagers. A few weeks ago, only ~ 30% of teenagers were vaccinated. Vaccination of teenagers has increased dramatically to stave off infections of the young. The good news is that infections in adults have been holding off fairly well since the Delta mutant first showed up way back in April. Deaths and hospitalizations remain extremely low because of vaccination and infections skewing young.
As I’ve stated in other threads, I predict that parts of the US will likely look like Israel right now. These would be regions that have high vaccination rates and those with moderate rates plus a high % of prior infection. The regions with low vaccination rates that have avoided outbreaks in the past will be hit hard in the next month. By fall, surges will have largely dissipated. This is all assuming that another variant is able to cause even more trouble.
A good read whose default response is pointing to COVID’s relatively low fatality rate. Not nearly enough is said about how the virus disables and for how long.
Stupid Australia only has 13% of the population fully vaccinated. And we now have two more full lockdowns in NSW and Vic as cases have taken off again. Way to go Aus, oh, and get fucked Scott Morrison.
The researchers examined 12 antibodies that Vir Biotechnology, a company based in San Francisco, California, that was involved in the study, isolated from people who had been infected with either SARS-CoV-2 or its close relative SARS-CoV.
One antibody, S2H97, stood out for its capacity to adhere to the binding domains of all the sarbecoviruses that the researchers tested. S2H97, which the authors dub a pan-sarbecovirus antibody, was able to prevent a range of SARS-CoV-2 variants and other sarbecoviruses from spreading among cells growing in the laboratory.
it targets a previously unseen and well-hidden region on the binding domain — a section that is revealed only when the domain pops up to bind to a cell’s receptor…that molecules targeting this binding-domain region could generate protection against multiple viruses, and might one day be used in pan-sarbecovirus vaccines.
The team also found that antibodies that could disable a wide variety of viruses targeted sections of the binding domain that tended not to change as the virus evolved.
This ‘super antibody’ for COVID fights off multiple coronaviruses
If you think it’s just about how many die, think again. A lot of people who contract COVID end up having debilitating symptoms are unable to return to their usual activities, including work. COVID isn’t just a respiratory disease; it is a full-on assault on the human body.
